1999
DOI: 10.1006/nbdi.1999.0262
|View full text |Cite
|
Sign up to set email alerts
|

The T102C Polymorphism of the 5-HT2A-Receptor Gene in Fibromyalgia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
89
1
9

Year Published

1999
1999
2020
2020

Publication Types

Select...
7
3

Relationship

2
8

Authors

Journals

citations
Cited by 176 publications
(102 citation statements)
references
References 28 publications
3
89
1
9
Order By: Relevance
“…It is defi ned by a T-C transition at position 102. This mutation does not alter the amino acid composition and has therefore no infl uence on the receptor protein [10] . The -1438G/A polymorphism, a novel G-A base change at position -1438 of the promoter region, has been detected, which is in very strong linkage disequilibrium with the T102C polymorphism of 5-HT 2A [11] .…”
Section: Introductionmentioning
confidence: 99%
“…It is defi ned by a T-C transition at position 102. This mutation does not alter the amino acid composition and has therefore no infl uence on the receptor protein [10] . The -1438G/A polymorphism, a novel G-A base change at position -1438 of the promoter region, has been detected, which is in very strong linkage disequilibrium with the T102C polymorphism of 5-HT 2A [11] .…”
Section: Introductionmentioning
confidence: 99%
“…Bondy et al [14] proposed that T102C polymorphism of the 5-HT2A receptor gene is associated with nociception, and that the fibromyalgia patients with T/T genotype had a lower pain threshold. According to Gursoy et al [15], the fibromyalgia patients with T/T genotype had more psychiatric symptoms as determined with SCL-90 symptom checklist scores.…”
Section: Discussionmentioning
confidence: 99%
“…In another study, these researches reported on a significantly different genotype distribution in FMS patients with a decrease in T/T and an increase in both T/C and C/C genotypes compared to the control population (30). Cohen and colleagues (31) performed genotyping in a group of 99 female FMS patients from two Israeli ethnic groups.…”
Section: Geneticsmentioning
confidence: 99%